The Novel Bispecific CD47-CD19 Antibody TG-1801 Potentiates the Activity of Ublituximab-Umbralisib (U2) Drug Combination in Preclinical Models of B-NHL

Drug Category : Array
Conference Category : Array
Lead Author : Ribeiro M et al.
Published Date : 09/06/2019
Download Link : https://www.tgtherapeutics.com/Final%20TG1801%20Poster%20ICML%202019.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top